ICU Medical Earnings: Here’s Why Investors Don’t Like These Results

ICU Medical, Inc. (NASDAQ:ICUI) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. The revenue miss is a negative sign to shareholders seeking high growth out of the company. Shares are down 8.08%.

ICU Medical, Inc. Earnings Cheat Sheet

Results: Adjusted Earnings Per Share decreased 23.81% to $0.48 in the quarter versus EPS of $0.63 in the year-earlier quarter.

Revenue: Rose 1.84% to $78.7 million from the year-earlier quarter.

Actual vs. Wall St. Expectations: ICU Medical, Inc. reported adjusted EPS income of $0.48 per share. By that measure, the company missed the mean analyst estimate of $0.66. It missed the average revenue estimate of $83.44 million.

Quoting Management: Scott Lamb, ICU Medical’s Chief Financial Officer, said, “Our top-line performance during the quarter was highlighted by continued growth in oncology which was offset by a decrease in critical care. International sales were up 4.4%, while domestic sales increased 0.8% year over year.”

Key Stats (on next page)…

Revenue increased 5.92% from $74.3 million in the previous quarter. EPS decreased 17.24% from $0.58 in the previous quarter.

Looking Forward: Analysts have a neutral outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings is a profit of $0.76 and has not changed. For the current year, the average estimate has moved up from a profit of $2.77 to a profit of $2.81 over the last ninety days.

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at] wallstcheatsheet.com)